Ingen Technologies, Inc. Products Fill Key Void for Medical Distributor

Ingen Technologies, Inc.'s Smart Nasal Cannula With Oxyview and Fingertip Pulse Oxymeter Solutions Fill a Void for Mountainside Medical Equipment Customers


YUCAIPA, Calif., Aug. 23, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative proprietary solutions for the $8 billion respiratory market, today announced that its products have filled a key void for Mountainside Medical Equipment (www.mountainside-medical.com), a veteran-owned worldwide distributor of medical supplies based in Upstate New York.

"For decades, our customers have requested a product allowing for simpler, more accurate monitoring of oxygen as provided by their concentrator or tank," said Marty Zarnock, Jr., Vice President of Mountainside Medical Equipment. "The Smart Nasal Cannula with Oxyview is now available to meet those demands, as nursing homes, hospital residents and at-home patients can now confidently receive oxygen safety and accurately as prescribed by their medical provider with these two products."

"The Ingen Fingertip Pulse Oximeter has also proven to be an asset in respiratory monitoring at Mountainside. With its large and bright LCD display, and colorful compact design, our customers' satisfaction and sales have improved tremendously. This product addition allows us to offer our customers a high-quality, state-of-the-art oximetry product at competitive pricing. The Mountainside team looks forward to further promotion of these products and the introduction of new products with similar success," he added.

Ingen's Smart Nasal Cannula uses the Oxyview Technology that is patented and proprietary. It monitors the actual flow of oxygen nearest the patient. The product has proven to reduce service calls while at the same time provides safety and assurance directly to the patient. The company projects to increase its sales over the next 12 months while targeting export sales to China, Canada, Australia and Europe.

With approximately 23 million patients in the U.S., and an estimated 600 million patients worldwide, who suffer from chronic obstructive pulmonary disease (COPD), Ingen stands to capture $200 million in revenues over the next five years. Since an average COPD patient uses two to three nasal cannulas each month to prevent bacteria build-up within the device, there is a growing and recurring demand for the product that benefits Ingen's top and bottom line results.

"After reporting a successful quarter earlier this month, we have been focused on rapidly expanding our sales efforts and attracting high quality distributors like Mountainside Medical Equipment," said Ingen CEO Scott Sand. "We are pleased to be working with one of the top medical supply companies on Google throughout the United States and Canada and we look forward to similar agreements going forward."

Investors can review our current fact sheet at the following link:
http://www.ingen-tech.com/PDFbin/FactSheet.pdf

Company Websites:

http://www.ingen-tech.com

http://www.smartnasalcannula.com/

http://www.ingenpulseoximeter.com/

About Mountainside Medical Equipment:

In the past three decades our values have stayed the same, great pricing, quick deliveries, and excellent customer service. Mountainside Medical has positioned itself in the medical supplies industry to service both the hospital and home care patients with products reflecting both innovation and exceptional price. Your continued support of our products has allowed us to grow and offer you the best pricing in the healthcare industry today. Whether you are a longtime friend or a new one, we will always welcome you and look forward to providing you the very best cost effective products and service possible. We are a family-owned small business, located in Upstate New York at the base of the Adirondack Mountains.

About Ingen:

Ingen is an ISO Certified medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the US, and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing US and Foreign Patents and a successful registration with the Food & Drug Administration. The company is establishing domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009 the SMART Nasal Cannula using Oxyview Technology was introduced as the world's first oxygen cannula with an in-line pneumatic oxygen flow meter. In 2010, the company introduced its new INGEN Pulse Oximeter. The Oxyview product line is available to the home care markets, commercial medical markets, aviation, automotive, and government sources. The company is licensed with the Department of Health and Human Services, and manufactures its products in the State of California. With approximately 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.

The Ingen Technologies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2472

Safe Harbor for Forward-Looking Statements:

This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission. 



            

Coordonnées